|
Market Closed -
Toronto S.E.
23:56:07 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 32.77 CAD | +0.34% |
|
+0.15% | +31.92% |
| 12:30pm | AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients | MT |
| 11:36am | AstraZeneca and Amgen announce positive Tezspire trial results in EoE | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | +0.34% | +0.15% | +31.92% | - | - | 238B |
-
|
-
|
-
|
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
